Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
10 2021
Historique:
received: 09 09 2020
accepted: 30 07 2021
pubmed: 2 10 2021
medline: 10 11 2021
entrez: 1 10 2021
Statut: ppublish

Résumé

Single-cell RNA sequencing has revealed extensive transcriptional cell state diversity in cancer, often observed independently of genetic heterogeneity, raising the central question of how malignant cell states are encoded epigenetically. To address this, here we performed multiomics single-cell profiling-integrating DNA methylation, transcriptome and genotype within the same cells-of diffuse gliomas, tumors characterized by defined transcriptional cell state diversity. Direct comparison of the epigenetic profiles of distinct cell states revealed key switches for state transitions recapitulating neurodevelopmental trajectories and highlighted dysregulated epigenetic mechanisms underlying gliomagenesis. We further developed a quantitative framework to directly measure cell state heritability and transition dynamics based on high-resolution lineage trees in human samples. We demonstrated heritability of malignant cell states, with key differences in hierarchal and plastic cell state architectures in IDH-mutant glioma versus IDH-wild-type glioblastoma, respectively. This work provides a framework anchoring transcriptional cancer cell states in their epigenetic encoding, inheritance and transition dynamics.

Identifiants

pubmed: 34594037
doi: 10.1038/s41588-021-00927-7
pii: 10.1038/s41588-021-00927-7
pmc: PMC8675181
mid: NIHMS1760761
doi:

Substances chimiques

Isocitrate Dehydrogenase EC 1.1.1.41
Polycomb Repressive Complex 2 EC 2.1.1.43

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1469-1479

Subventions

Organisme : NCI NIH HHS
ID : K99 CA248955
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA014051
Pays : United States
Organisme : NCI NIH HHS
ID : K12 CA090354
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA258763
Pays : United States
Organisme : NCI NIH HHS
ID : R33 CA202820
Pays : United States
Organisme : NCI NIH HHS
ID : DP2 CA239065
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA180922
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA245523
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NHGRI NIH HHS
ID : RM1 HG011014
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189–196 (2016).
pubmed: 27124452 pmcid: 4944528 doi: 10.1126/science.aad0501
Nam, A. S. et al. Somatic mutations and cell identity linked by genotyping of transcriptomes. Nature 571, 355–360 (2019).
pubmed: 31270458 pmcid: 6782071 doi: 10.1038/s41586-019-1367-0
Puram, S. V. et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell 171, 1611–1624 (2017).
pubmed: 29198524 pmcid: 5878932 doi: 10.1016/j.cell.2017.10.044
Hata, A. N. et al. Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition. Nat. Med. 22, 262–269 (2016).
pubmed: 26828195 pmcid: 4900892 doi: 10.1038/nm.4040
Shaffer, S. M. et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature 546, 431–435 (2017).
pubmed: 28607484 pmcid: 5542814 doi: 10.1038/nature22794
Shaffer, S. M. et al. Memory sequencing reveals heritable single-cell gene expression programs associated with distinct cellular behaviors. Cell 182, 947–959 (2020).
Tirosh, I. et al. Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma. Nature 539, 309–313 (2016).
pubmed: 27806376 pmcid: 5465819 doi: 10.1038/nature20123
Frieda, K. L. et al. Synthetic recording and in situ readout of lineage information in single cells. Nature 541, 107–111 (2017).
pubmed: 27869821 doi: 10.1038/nature20777
Spanjaard, B. et al. Simultaneous lineage tracing and cell-type identification using CRISPR–Cas9-induced genetic scars. Nat. Biotechnol. 36, 469–473 (2018).
pubmed: 29644996 pmcid: 5942543 doi: 10.1038/nbt.4124
Raj, B. et al. Simultaneous single-cell profiling of lineages and cell types in the vertebrate brain. Nat. Biotechnol. 36, 442–450 (2018).
pubmed: 29608178 pmcid: 5938111 doi: 10.1038/nbt.4103
McKenna, A. et al. Whole-organism lineage tracing by combinatorial and cumulative genome editing. Science 353, aaf7907 (2016).
Alemany, A., Florescu, M., Baron, C. S., Peterson-Maduro, J. & van Oudenaarden, A. Whole-organism clone tracing using single-cell sequencing. Nature 556, 108–112 (2018).
pubmed: 29590089 doi: 10.1038/nature25969
Lathia, J. D., Mack, S. C., Mulkearns-Hubert, E. E., Valentim, C. L. L. & Rich, J. N. Cancer stem cells in glioblastoma. Genes Dev. 29, 1203–1217 (2015).
pubmed: 26109046 pmcid: 4495393 doi: 10.1101/gad.261982.115
Gimple, R. C., Bhargava, S., Dixit, D. & Rich, J. N. Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer. Genes Dev. 33, 591–609 (2019).
pubmed: 31160393 pmcid: 6546059 doi: 10.1101/gad.324301.119
Suvà, M. L. et al. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell 157, 580–594 (2014).
pubmed: 24726434 pmcid: 4004670 doi: 10.1016/j.cell.2014.02.030
Suvà, M. L. & Tirosh, I. The glioma stem cell model in the era of single-cell genomics. Cancer Cell 37, 630–636 (2020).
pubmed: 32396858 doi: 10.1016/j.ccell.2020.04.001
Bao, S. et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756–760 (2006).
pubmed: 17051156 doi: 10.1038/nature05236
Liau, B. B. et al. Adaptive chromatin remodeling drives glioblastoma stem cell plasticity and drug tolerance. Cell Stem Cell 20, 233–246 (2017).
pubmed: 27989769 doi: 10.1016/j.stem.2016.11.003
Chen, J. et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488, 522–526 (2012).
pubmed: 22854781 pmcid: 3427400 doi: 10.1038/nature11287
Filbin, M. G. et al. Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science 360, 331–335 (2018).
pubmed: 29674595 pmcid: 5949869 doi: 10.1126/science.aao4750
Neftel, C. et al. An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 178, 835–849 (2019).
pubmed: 31327527 pmcid: 6703186 doi: 10.1016/j.cell.2019.06.024
Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396–1401 (2014).
pubmed: 24925914 pmcid: 4123637 doi: 10.1126/science.1254257
Venteicher, A. S. et al. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science 355, eaai8478 (2017).
pubmed: 28360267 pmcid: 5519096 doi: 10.1126/science.aai8478
Garofano, L. et al. Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities. Nat. Cancer 2, 141–156 (2021).
pubmed: 33681822 pmcid: 7935068 doi: 10.1038/s43018-020-00159-4
Richards, L. M. et al. Gradient of developmental and injury response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity. Nat. Cancer 2, 157–173 (2021).
doi: 10.1038/s43018-020-00154-9 pubmed: 35122077
Castellan, M. et al. Single-cell analyses reveal YAP/TAZ as regulators of stemness and cell plasticity in glioblastoma. Nat. Cancer 2, 174–188 (2021).
pubmed: 33644767 doi: 10.1038/s43018-020-00150-z
Latil, M. et al. Cell-type-specific chromatin states differentially prime squamous cell carcinoma tumor-initiating cells for epithelial to mesenchymal transition. Cell Stem Cell 20, 191–204 (2017).
pubmed: 27889319 doi: 10.1016/j.stem.2016.10.018
Flavahan, W. A., Gaskell, E. & Bernstein, B. E. Epigenetic plasticity and the hallmarks of cancer. Science 357, eaal2380 (2017).
pubmed: 28729483 pmcid: 5940341 doi: 10.1126/science.aal2380
Meir, Z., Mukamel, Z., Chomsky, E., Lifshitz, A. & Tanay, A. Single-cell analysis of clonal maintenance of transcriptional and epigenetic states in cancer cells. Nat. Genet. 52, 709–718 (2020).
pubmed: 32601473 pmcid: 7610382 doi: 10.1038/s41588-020-0645-y
Guilhamon, P. et al. Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival. eLife 10, e64090 (2021).
pubmed: 33427645 pmcid: 7847307 doi: 10.7554/eLife.64090
La Manno, G. et al. RNA velocity of single cells. Nature 560, 494–498 (2018).
pubmed: 30089906 pmcid: 6130801 doi: 10.1038/s41586-018-0414-6
Fine, H. A. Malignant gliomas: simplifying the complexity. Cancer Discov. 9, 1650–1652 (2019).
pubmed: 31792122 doi: 10.1158/2159-8290.CD-19-1081
Gaiti, F. et al. Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia. Nature 569, 576–580 (2019).
pubmed: 31092926 pmcid: 6533116 doi: 10.1038/s41586-019-1198-z
Picelli, S. et al. Full-length RNA-seq from single cells using Smart-seq2. Nat. Protoc. 9, 171–181 (2014).
pubmed: 24385147 doi: 10.1038/nprot.2014.006
Morton, A. R. et al. Functional enhancers shape extrachromosomal oncogene amplifications. Cell 179, 1330–1341 (2019).
pubmed: 31761532 pmcid: 7241652 doi: 10.1016/j.cell.2019.10.039
Sun, W. et al. The association between copy number aberration, DNA methylation and gene expression in tumor samples. Nucleic Acids Res. 46, 3009–3018 (2018).
pubmed: 29529299 pmcid: 5887505 doi: 10.1093/nar/gky131
O’Hagan, H. M., Mohammad, H. P. & Baylin, S. B. Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island. PLoS Genet. 4, e1000155 (2008).
pubmed: 18704159 pmcid: 2491723 doi: 10.1371/journal.pgen.1000155
Davoli, T. et al. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell 155, 948–962 (2013).
pubmed: 24183448 pmcid: 3891052 doi: 10.1016/j.cell.2013.10.011
Ceccarelli, M. et al. Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164, 550–563 (2016).
pubmed: 26824661 pmcid: 4754110 doi: 10.1016/j.cell.2015.12.028
McLendon, R. et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061–1068 (2008).
doi: 10.1038/nature07385
Brennan, C. W. et al. The somatic genomic landscape of glioblastoma. Cell 155, 462–477 (2013).
pubmed: 24120142 pmcid: 3910500 doi: 10.1016/j.cell.2013.09.034
Capper, D. et al. DNA methylation-based classification of central nervous system tumours. Nature 555, 469–474 (2018).
pubmed: 29539639 pmcid: 6093218 doi: 10.1038/nature26000
Pine, A. R. et al. Tumor microenvironment is critical for the maintenance of cellular states found in primary glioblastomas. Cancer Discov. https://doi.org/10.1158/2159-8290.CD-20-0057 (2020).
Wang, Q. et al. Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell 32, 42–56 (2017).
pubmed: 28697342 pmcid: 5599156 doi: 10.1016/j.ccell.2017.06.003
Verhaak, R. G. W. et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98–110 (2010).
pubmed: 20129251 pmcid: 2818769 doi: 10.1016/j.ccr.2009.12.020
Ben-Porath, I. et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40, 499–507 (2008).
pubmed: 18443585 pmcid: 2912221 doi: 10.1038/ng.127
Rheinbay, E. et al. An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma. Cell Rep. 3, 1567–1579 (2013).
pubmed: 23707066 pmcid: 3774301 doi: 10.1016/j.celrep.2013.04.021
Suvà, M.-L. et al. EZH2 is essential for glioblastoma cancer stem cell maintenance. Cancer Res. 69, 9211–9218 (2009).
pubmed: 19934320 doi: 10.1158/0008-5472.CAN-09-1622
Natsume, A. et al. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma. Cancer Res. 73, 4559–4570 (2013).
pubmed: 23720055 doi: 10.1158/0008-5472.CAN-13-0109
ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012).
doi: 10.1038/nature11247
O’Connor, T., Grant, C. E., Bodén, M. & Bailey, T. L. T-Gene: improved target gene prediction. Bioinformatics https://doi.org/10.1093/bioinformatics/btaa227 (2020).
Reddington, J. P., Sproul, D. & Meehan, R. R. DNA methylation reprogramming in cancer: Does it act by re-configuring the binding landscape of Polycomb repressive complexes? Bioessays 36, 134–140 (2014).
pubmed: 24277643 doi: 10.1002/bies.201300130
Douillet, D. et al. Uncoupling histone H3K4 trimethylation from developmental gene expression via an equilibrium of COMPASS, Polycomb and DNA methylation. Nat. Genet. https://doi.org/10.1038/s41588-020-0618-1 (2020).
Bintu, L. et al. Dynamics of epigenetic regulation at the single-cell level. Science 351, 720–724 (2016).
pubmed: 26912859 pmcid: 5108652 doi: 10.1126/science.aab2956
Wang, L. et al. The phenotypes of proliferating glioblastoma cells reside on a single axis of variation. Cancer Discov. 9, 1708–1719 (2019).
pubmed: 31554641 pmcid: 7161589 doi: 10.1158/2159-8290.CD-19-0329
Hoffmann, A., Sportelli, V., Ziller, M. & Spengler, D. Switch-like roles for Polycomb proteins from neurodevelopment to neurodegeneration. Epigenomes 1, 21 (2017).
doi: 10.3390/epigenomes1030021
Xu, W. et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell 19, 17–30 (2011).
pubmed: 21251613 pmcid: 3229304 doi: 10.1016/j.ccr.2010.12.014
Turcan, S. et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483, 479–483 (2012).
pubmed: 22343889 pmcid: 3351699 doi: 10.1038/nature10866
Lu, F., Liu, Y., Jiang, L., Yamaguchi, S. & Zhang, Y. Role of Tet proteins in enhancer activity and telomere elongation. Genes Dev. https://doi.org/10.1101/gad.248005.114 (2014).
Hon, G. C. et al. 5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation. Mol. Cell 56, 286–297 (2014).
pubmed: 25263596 pmcid: 4319980 doi: 10.1016/j.molcel.2014.08.026
Ginno, P. A. et al. A genome-scale map of DNA methylation turnover identifies site-specific dependencies of DNMT and TET activity. Nat. Commun. 11, 2680 (2020).
pubmed: 32471981 pmcid: 7260214 doi: 10.1038/s41467-020-16354-x
Creyghton, M. P. et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl Acad. Sci. USA 107, 21931–21936 (2010).
pubmed: 21106759 pmcid: 3003124 doi: 10.1073/pnas.1016071107
Landau, D. A. et al. Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia. Cancer Cell 26, 813–825 (2014).
pubmed: 25490447 pmcid: 4302418 doi: 10.1016/j.ccell.2014.10.012
Shipony, Z. et al. Dynamic and static maintenance of epigenetic memory in pluripotent and somatic cells. Nature 513, 115–119 (2014).
pubmed: 25043040 doi: 10.1038/nature13458
Landan, G. et al. Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues. Nat. Genet. 44, 1207–1214 (2012).
pubmed: 23064413 doi: 10.1038/ng.2442
Pan, H. et al. Epigenomic evolution in diffuse large B-cell lymphomas. Nat. Commun. 6, 6921 (2015).
pubmed: 25891015 doi: 10.1038/ncomms7921
Jones, P. A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13, 484–492 (2012).
pubmed: 22641018 doi: 10.1038/nrg3230
Turcan, S. et al. Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence. Nat. Genet. 50, 62–72 (2018).
pubmed: 29180699 doi: 10.1038/s41588-017-0001-z
Núñez, F. J. et al. IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response. Sci. Transl. Med. 11, eaaq1427 (2019).
pubmed: 30760578 pmcid: 6400220 doi: 10.1126/scitranslmed.aaq1427
Flavahan, W. A. et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529, 110–114 (2016).
pubmed: 26700815 doi: 10.1038/nature16490
Brocks, D. et al. Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer. Cell Rep. 8, 798–806 (2014).
pubmed: 25066126 doi: 10.1016/j.celrep.2014.06.053
Roerink, S. F. et al. Intra-tumour diversification in colorectal cancer at the single-cell level. Nature 556, 457–462 (2018).
pubmed: 29643510 doi: 10.1038/s41586-018-0024-3
Shibata, D. Mutation and epigenetic molecular clocks in cancer. Carcinogenesis 32, 123–128 (2011).
pubmed: 21076057 doi: 10.1093/carcin/bgq239
Moran, P. A. P. Notes on continuous stochastic phenomena. Biometrika 37, 17–23 (1950).
pubmed: 15420245 doi: 10.1093/biomet/37.1-2.17
Maddison, W. P., Midford, P. E. & Otto, S. P. Estimating a binary character’s effect on speciation and extinction. Syst. Biol. 56, 701–710 (2007).
pubmed: 17849325 doi: 10.1080/10635150701607033
Stadler, T. & Bonhoeffer, S. Uncovering epidemiological dynamics in heterogeneous host populations using phylogenetic methods. Philos. Trans. R. Soc. B Biol. Sci. 368, 20120198 (2013).
doi: 10.1098/rstb.2012.0198
Boyle, A. P. et al. High-resolution mapping and characterization of open chromatin across the genome. Cell 132, 311–322 (2008).
pubmed: 18243105 pmcid: 2669738 doi: 10.1016/j.cell.2007.12.014
Bell, R. E. et al. Enhancer methylation dynamics contribute to cancer plasticity and patient mortality. Genome Res. 26, 601–611 (2016).
pubmed: 26907635 pmcid: 4864467 doi: 10.1101/gr.197194.115
Ziller, M. J. et al. Charting a dynamic DNA methylation landscape of the human genome. Nature 500, 477–481 (2013).
pubmed: 23925113 pmcid: 3821869 doi: 10.1038/nature12433
Pastore, A. et al. Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLL. Nat. Commun. 10, 1874 (2019).
pubmed: 31015400 pmcid: 6478836 doi: 10.1038/s41467-019-09645-5
Irizarry, R. A. et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 41, 178–186 (2009).
pubmed: 19151715 pmcid: 2729128 doi: 10.1038/ng.298
Polak, P. et al. A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer. Nat. Genet. 49, 1476–1486 (2017).
pubmed: 28825726 pmcid: 7376751 doi: 10.1038/ng.3934
Izzo, F. et al. DNA methylation disruption reshapes the hematopoietic differentiation landscape. Nat. Genet. 52, 378–387 (2020).
pubmed: 32203468 pmcid: 7216752 doi: 10.1038/s41588-020-0595-4
Challen, G. A. et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nat. Genet. 44, 23–31 (2011).
pubmed: 22138693 pmcid: 3637952 doi: 10.1038/ng.1009
Klughammer, J. et al. The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space. Nat. Med. 24, 1611–1624 (2018).
pubmed: 30150718 pmcid: 6181207 doi: 10.1038/s41591-018-0156-x
Boyer, L. A. et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441, 349–353 (2006).
pubmed: 16625203 doi: 10.1038/nature04733
Margueron, R. & Reinberg, D. The Polycomb complex PRC2 and its mark in life. Nature 469, 343–349 (2011).
pubmed: 21248841 pmcid: 3760771 doi: 10.1038/nature09784
Bernstein, B. E. et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315–326 (2006).
pubmed: 16630819 doi: 10.1016/j.cell.2006.02.041
Boulard, M., Edwards, J. R. & Bestor, T. H. FBXL10 protects Polycomb-bound genes from hypermethylation. Nat. Genet. 47, 479–485 (2015).
pubmed: 25848754 doi: 10.1038/ng.3272
Meissner, A. et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454, 766–770 (2008).
pubmed: 18600261 pmcid: 2896277 doi: 10.1038/nature07107
Domcke, S. et al. A human cell atlas of fetal chromatin accessibility. Science 370, eaba7612 (2020).
Mohn, F. et al. Lineage-specific Polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol. Cell 30, 755–766 (2008).
pubmed: 18514006 doi: 10.1016/j.molcel.2008.05.007
Suvà, M. L., Riggi, N. & Bernstein, B. E. Epigenetic reprogramming in cancer. Science 339, 1567–1570 (2013).
pubmed: 23539597 doi: 10.1126/science.1230184
Alcantara Llaguno, S. R. & Parada, L. F. Cell of origin of glioma: biological and clinical implications. Br. J. Cancer 115, 1445–1450 (2016).
pubmed: 27832665 pmcid: 5155355 doi: 10.1038/bjc.2016.354
Chaffer, C. L. et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc. Natl Acad. Sci. USA 108, 7950–7955 (2011).
pubmed: 21498687 pmcid: 3093533 doi: 10.1073/pnas.1102454108
Morris, V. et al. Single-cell analysis reveals mechanisms of plasticity of leukemia initiating cells. Preprint at bioRxiv https://doi.org/10.1101/2020.04.29.066332 (2020).
Lieberman, E., Hauert, C. & Nowak, M. A. Evolutionary dynamics on graphs. Nature 433, 312–316 (2005).
pubmed: 15662424 doi: 10.1038/nature03204
Lappalainen, T. & Greally, J. M. Associating cellular epigenetic models with human phenotypes. Nat. Rev. Genet. 18, 441–451 (2017).
pubmed: 28555657 doi: 10.1038/nrg.2017.32
Angermueller, C., Lee, H. J., Reik, W. & Stegle, O. DeepCpG: accurate prediction of single-cell DNA methylation states using deep learning. Genome Biol. 18, 67 (2017).
pubmed: 28395661 pmcid: 5387360 doi: 10.1186/s13059-017-1189-z
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886 doi: 10.1093/bioinformatics/bts635
Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).
pubmed: 21816040 pmcid: 3163565 doi: 10.1186/1471-2105-12-323
Van den Berge, K. et al. Observation weights unlock bulk RNA-seq tools for zero inflation and single-cell applications. Genome Biol. 19, 24 (2018).
pubmed: 29478411 pmcid: 6251479 doi: 10.1186/s13059-018-1406-4
Risso, D., Perraudeau, F., Gribkova, S., Dudoit, S. & Vert, J.-P. A general and flexible method for signal extraction from single-cell RNA-seq data. Nat. Commun. 9, 284 (2018).
Van den Berge, K., Soneson, C., Robinson, M. D. & Clement, L. stageR: a general stage-wise method for controlling the gene-level false discovery rate in differential expression and differential transcript usage. Genome Biol. 18, 151 (2017).
pubmed: 28784146 pmcid: 5547545 doi: 10.1186/s13059-017-1277-0
Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).
pubmed: 29409532 pmcid: 5802054 doi: 10.1186/s13059-017-1382-0
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).
Seshan, V. E. & Olshen, A. B. DNAcopy: a package for analyzing DNA copy data (v1.60.0). R package. (2021).
Ernst, J. & Kellis, M. ChromHMM: automating chromatin-state discovery and characterization. Nat. Methods 9, 215–216 (2012).
pubmed: 22373907 pmcid: 3577932 doi: 10.1038/nmeth.1906
Robinson, D. F. & Foulds, L. R. Comparison of phylogenetic trees. Math. Biosci. 53, 131–147 (1981).
doi: 10.1016/0025-5564(81)90043-2
Gittleman, J. L. & Kot, M. Adaptation: statistics and a null model for estimating phylogenetic effects. Syst. Biol. 39, 227–241 (1990).
Wartenberg, D. Multivariate spatial correlation: a method for exploratory geographical analysis. Geographical Anal. 17, 263–283 (1985).
doi: 10.1111/j.1538-4632.1985.tb00849.x
Czaplewski, R. L. Expected Value and Variance of Moran’s Bivariate Spatial Autocorrelation Statistic for a Permutation Test (US Department of Agriculture, Forest Service, Rocky Mountain Forest and Range Experiment Station, 1993).
FitzJohn, R. G. Diversitree: comparative phylogenetic analyses of diversification in R. Methods Ecol. Evol. 3, 1084–1092 (2012).
doi: 10.1111/j.2041-210X.2012.00234.x
Revell, L. J. phytools: an R package for phylogenetic comparative biology (and other things). Methods Ecol. Evol. 3, 217–223 (2012).
doi: 10.1111/j.2041-210X.2011.00169.x
Xiang, Y., Gubian, S., Suomela, B. & Hoeng, J. Generalized simulated annealing for global optimization: the GenSA package. R Journal 5, 13 (2013).
doi: 10.32614/RJ-2013-002
Bolker, B. Maximum likelihood estimation and analysis with the bbmle package (v1.0.23.1). R package. (2021).
Gaiti, F., Silverbush, D., Schiffman, J. & Kluegel, L. Single-cell multi-omics profiling of human gliomas. Zenodo https://doi.org/10.5281/zenodo.4776456 (2021).

Auteurs

Ronan Chaligne (R)

New York Genome Center, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Federico Gaiti (F)

New York Genome Center, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Dana Silverbush (D)

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Joshua S Schiffman (JS)

New York Genome Center, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Hannah R Weisman (HR)

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Lloyd Kluegel (L)

New York Genome Center, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Simon Gritsch (S)

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Sunil D Deochand (SD)

New York Genome Center, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

L Nicolas Gonzalez Castro (LN)

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.
Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Alyssa R Richman (AR)

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Johanna Klughammer (J)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Tommaso Biancalani (T)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Christoph Muus (C)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.

Caroline Sheridan (C)

Weill Cornell Medicine, New York, NY, USA.

Alicia Alonso (A)

Weill Cornell Medicine, New York, NY, USA.

Franco Izzo (F)

New York Genome Center, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Jane Park (J)

New York Genome Center, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Orit Rozenblatt-Rosen (O)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Genentech, South San Francisco, CA, USA.

Aviv Regev (A)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Howard Hughes Medical Institute, Koch Institute for Integrative Cancer Research, Department of Biology, MIT, Cambridge, MA, USA.
Genentech, South San Francisco, CA, USA.

Mario L Suvà (ML)

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. suva.mario@mgh.harvard.edu.
Broad Institute of Harvard and MIT, Cambridge, MA, USA. suva.mario@mgh.harvard.edu.

Dan A Landau (DA)

New York Genome Center, New York, NY, USA. dlandau@nygenome.org.
Weill Cornell Medicine, New York, NY, USA. dlandau@nygenome.org.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH